Please title this page. (Page 9)

Radiopharmaceuticals

14: RADIOPHARMACEUTICALS FOR PROTEIN-LOSS ENTEROPATHY STUDIES

Traditionally ⁵¹Cr- chromic chloride has been used for protein-loss enteropathy studies. However ⁵¹Cr-chromic chloride is only available as a radiochemical and not a a sterile solution licenced for patient administration. ¹¹¹In-indium transferrin has been proposed as an alternative to ⁵¹Cr-chromic chloride for protein-loss enteropathy studies. Further information is available in the following reference:

Carpani de Kaski M, Peters AM, Bradley D and Hodgson HJ. (1996). Detection and quantification of protein-losing enteropathy with indium-111 transferrin. European Journal of Nuclear Medicine; 23: 530-533

-----------------------------

Back to Formulary Section Back to Radiopharmacy Handbook Index

	14: RADIOPHARMACEUTICALS FOR PROTEIN-LOSS ENTEROPATHY STUDIES

	Traditionally ⁵¹Cr- chromic chloride has been used for protein-loss enteropathy studies. However ⁵¹Cr-chromic chloride is only available as a radiochemical and not a a sterile solution licenced for patient administration. ¹¹¹In-indium transferrin has been proposed as an alternative to ⁵¹Cr-chromic chloride for protein-loss enteropathy studies. Further information is available in the following reference:
	Carpani de Kaski M, Peters AM, Bradley D and Hodgson HJ. (1996). Detection and quantification of protein-losing enteropathy with indium-111 transferrin. European Journal of Nuclear Medicine; 23: 530-533















	-----------------------------